About
Overview
Management
Board of Directors
Scientific Advisory Board
Our Science
iNKT Cells
ARDS & Infectious Diseases
Cancer
GvHD
Publications
Platform
Manufacturing
Engineering
Pipeline
Investor & Media
Overview
Press Releases
Events and Presentations
Stock Information
Financials & Filings
Corporate Governance
Careers
Contact
Home
Press Releases - MiNK Therapeutics
Press
Releases - MiNK Therapeutics
MiNK Therapeutics to Present Three Abstracts on Novel Allogeneic iNKT Programs at SITC
October 1, 2021